Amoxicillin/clavulanic acid

PreclinicalSmall molecule

Amoxicillin/clavulanic acid is one of 9 small molecule programs targeting Impacted Mandibular Third Molar Extraction. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Impacted Mandibular Third Molar ExtractionRecruiting

Surgical Site InfectionsCompleted

Impacted Mandibular Third Molar ExtractionPreclinical

Recruiting

Surgical Site InfectionsPreclinical

Completed

Competition

Competitive Landscape

6 competitors in Surgical Site Infections

#DrugCompanyPhaseTrials

Betadine

BBecton, Dickinson and Company

Phase 3

1 2

Peridex

DDexcel Pharma Technologies Ltd.

Preclinical

2 3

Ancef

BBaxter Healthcare Corporation

Preclinical

2 4

Bactroban

PPadagis LLC

Preclinical

1 5

Amoxicillin/clavulanic acid

Lundbeck

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Diverticulitis1 trial

Randomized Clinical Trial to Compare the Treatment of Mild Acute Diverticulitis With or Without Antibiotics

Completed·CCorporacion Parc Tauli·Phase 4·NCT02785549·480 enrolled

Adult1 trial

A Trial Investigating Lu AF28996 in Healthy Adult Participants

Completed· Lundbeck logo

Lundbeck·Phase 1·NCT06277609·22 enrolled

Pulmonary Tuberculosis1 trial

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

Completed·NNational University Hospital, Singapore·Phase 2·NCT02381470·58 enrolled

Antibiotic Prophylaxis1 trial

Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures

Terminated·IInsel Gruppe AG, University Hospital Bern·Phase 4·NCT01583062·217 enrolled

Tuberculosis1 trial

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers

Completed·NNational University Hospital, Singapore·Phase 1·NCT02393586·43 enrolled

3 more indications

Pneumonia1 trial

Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia

Unknown status·RRadboud University Medical Center·Phase 2/3·NCT01598402·106 enrolled

Surgical Site Infections1 trial

Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections

Completed·SSwiss Tropical & Public Health Institute·N/A·NCT00801099·276 enrolled

Impacted Mandibular Third Molar Extraction1 trial

Comparison of Postoperative Effects of PRF and Corticosteroid Treatments in Impacted Third Molar Surgery

Recruiting·FFinal International University·Preclinical·NCT07742826·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Amoxicillin/clavulanic acid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Amoxicillin/clavulanic acid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Amoxicillin/clavulanic acid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Lundbeck company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Lundbeck

Amoxicillin/clavulanic acid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Diverticulitis1 trial

Adult1 trial

Pulmonary Tuberculosis1 trial

Antibiotic Prophylaxis1 trial

Tuberculosis1 trial

Pneumonia1 trial

Surgical Site Infections1 trial

Impacted Mandibular Third Molar Extraction1 trial

References

Drug Info

Quick Facts

Related News